Catalent
CTLT
#1583
Rank
ยฃ8.31 B
Marketcap
ยฃ45.80
Share price
-0.35%
Change (1 day)
19.40%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total assets

Total assets on the balance sheet as of June 2024 : ยฃ7.43 B

According to Catalent's latest financial reports the company's total assets are ยฃ7.43 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Catalent - Total assets on balance sheet (from 2013 to 2024)

Total assets by year

Year Total assets Change
2023-06-30ยฃ8.47 B-1.75%
2022-06-30ยฃ8.62 B30.69%
2021-06-30ยฃ6.60 B5.1%
2020-06-30ยฃ6.28 B28.96%
2019-06-30ยฃ4.87 B42%
2018-06-30ยฃ3.43 B29.17%
2017-06-30ยฃ2.65 B15.43%
2016-06-30ยฃ2.30 B15.5%
2015-06-30ยฃ1.99 B9.8%
2014-06-30ยฃ1.81 B-6.44%
2013-06-30ยฃ1.93 B-3.1%
2012-06-30ยฃ2.00 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ยฃ1.00 B-86.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.28 B-96.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.65 B 16.50%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ0.29 B-95.97%๐Ÿ‡บ๐Ÿ‡ธ USA